Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | fosamprenavir | |
Synonyms |
GW433908 fos-amprenavir VX-175 GW433908G GW-908 (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester GW 433908 Lexiva fosamprenavir sodium VX 175 GW 433908G Telzir GW 433908A GW 908 GW-433908 GW-433908A fosamprenavir calcium GW-433908G |
|
ID |
http://purl.bioontology.org/ontology/MESH/C426859 |
|
altLabel |
GW433908 fos-amprenavir VX-175 GW433908G GW-908 (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) ester GW 433908 Lexiva fosamprenavir sodium VX 175 GW 433908G Telzir GW 433908A GW 908 GW-433908 GW-433908A fosamprenavir calcium GW-433908G
|
|
cui |
C1321660 C0966430 C1962504 C1314930 C5772737 C1176315 C1320129 C5772738 C1366241
|
|
HM |
D002219 D005663 D013449
|
|
Inverse of RB |
WOU1621EEG ID1GU2627N XSG28FSA0W 0
|
|
isa | ||
LT |
TRD
|
|
Mapped to |
http://purl.bioontology.org/ontology/MESH/D013449 |
|
MDA |
20010530
|
|
MeSH Frequency |
169
|
|
MMR |
20220804
|
|
notation |
C426859
|
|
PA |
D019380 D017320
|
|
PI |
*PRODRUGS (2001-2002)
|
|
prefLabel |
fosamprenavir
|
|
RR |
ID1GU2627N XSG28FSA0W
|
|
SC |
1
|
|
Scope Statement |
a prodrug of the protease inhibitor amprenavir
|
|
SRC |
AIDS Patient Care STDS 2001 Mar;15(3):174
|
|
TERMUI |
T526717 T526713 T001110570 T526719 T001110568 T676932 T001110567 T526715 T448416 T448415 T526724 T526721 T526718 T526716 T526723 T526720 T001110569 T595548 T595547
|
|
TH |
NLM (2002) NLM (2004) FDA SRS (2013) FDA SRS (2017) NLM (2001) NLM (2021) USAN (19XX) INN (19XX) NLM (2006)
|
|
tui |
T109 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping